Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| non-classical monocyte | 6 studies | 27% ± 14% |
Insufficient scRNA-seq data for expression of ADGRE1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| lung | 100% | 336.18 | 577 / 578 | 47% | 1.66 | 541 / 1155 |
| spleen | 100% | 1784.98 | 241 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 98% | 3075.47 | 915 / 929 | 0% | 0 | 0 / 0 |
| kidney | 29% | 16.54 | 26 / 89 | 63% | 2.36 | 571 / 901 |
| lymph node | 0% | 0 | 0 / 0 | 79% | 11.12 | 23 / 29 |
| breast | 30% | 13.30 | 137 / 459 | 46% | 1.00 | 512 / 1118 |
| bladder | 43% | 19.10 | 9 / 21 | 32% | 1.82 | 163 / 504 |
| intestine | 45% | 33.46 | 434 / 966 | 23% | 0.59 | 123 / 527 |
| liver | 56% | 55.04 | 126 / 226 | 12% | 0.43 | 47 / 406 |
| stomach | 26% | 19.71 | 95 / 359 | 31% | 0.67 | 89 / 286 |
| brain | 19% | 14.35 | 494 / 2642 | 38% | 1.75 | 266 / 705 |
| adipose | 49% | 36.51 | 585 / 1204 | 0% | 0 | 0 / 0 |
| prostate | 42% | 26.08 | 102 / 245 | 5% | 0.08 | 26 / 502 |
| ovary | 7% | 2.61 | 12 / 180 | 34% | 0.92 | 146 / 430 |
| pancreas | 9% | 4.18 | 30 / 328 | 31% | 0.62 | 56 / 178 |
| adrenal gland | 35% | 16.42 | 90 / 258 | 5% | 0.12 | 11 / 230 |
| skin | 1% | 0.42 | 24 / 1809 | 37% | 1.21 | 174 / 472 |
| uterus | 13% | 7.29 | 22 / 170 | 25% | 1.06 | 114 / 459 |
| thymus | 16% | 6.95 | 102 / 653 | 18% | 0.50 | 107 / 605 |
| esophagus | 11% | 5.50 | 159 / 1445 | 20% | 0.84 | 37 / 183 |
| tonsil | 0% | 0 | 0 / 0 | 29% | 1.06 | 13 / 45 |
| blood vessel | 26% | 14.98 | 341 / 1335 | 0% | 0 | 0 / 0 |
| heart | 18% | 8.48 | 154 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 5% | 0.08 | 4 / 80 |
| muscle | 1% | 0.43 | 11 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0002250 | Biological process | adaptive immune response |
| GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
| GO_0007189 | Biological process | adenylate cyclase-activating G protein-coupled receptor signaling pathway |
| GO_0007155 | Biological process | cell adhesion |
| GO_0007166 | Biological process | cell surface receptor signaling pathway |
| GO_0009897 | Cellular component | external side of plasma membrane |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0004930 | Molecular function | G protein-coupled receptor activity |
| GO_0005509 | Molecular function | calcium ion binding |
| Gene name | ADGRE1 |
| Protein name | Adhesion G protein-coupled receptor E1 Adhesion G protein-coupled receptor E1 (EGF-like module receptor 1) (EGF-like module-containing mucin-like hormone receptor-like 1) (EMR1 hormone receptor) |
| Synonyms | EMR1 TM7LN3 |
| Description | FUNCTION: Orphan receptor involved in cell adhesion and probably in cell-cell interactions specifically involving cells of the immune system. May play a role in regulatory T-cells (Treg) development. . |
| Accessions | M0R2G7 Q14246 ENST00000381407.9 [Q14246-5] ENST00000312053.9 [Q14246-1] ENST00000250572.12 [Q14246-2] ENST00000450315.7 [Q14246-4] ENST00000381404.8 [Q14246-3] ENST00000595026.1 |